GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM9044
Query DataSets for GSM9044
Status
Public on Feb 29, 2004
Title
hc5
Sample type
RNA
Source name
adipose tissue
Organism
Homo sapiens
Extracted molecule
total RNA
Description
Total RNA was extracted from umbilical subcutaneous adipose tissue from an individual affected with FCHL and exhibiting the USF1 susceptibility haplotype
Submission date
Aug 13, 2003
Last update date
May 28, 2005
Contact name
Massimiliano Gentile
E-mail(s)
[email protected]
Phone
+358-9-47448726
URL
http://www.bioinfo.helsinki.fi
Organization name
Biomedicum Helsinki
Department
Biomedicum Bioinformatics Unit
Lab
Biomedicum Bioinformatics Unit
Street address
Haartmaninkatu 8
City
Helsinki
ZIP/Postal code
000 14
Country
Finland
Platform ID
GPL96
Series (1)
GSE590
USF1 haplotype comparison
Data table header descriptions
ID_REF
VALUE
signal intensity
ABS_CALL
quality flag: absent, marginal or present
DETECTION P-VALUE
p-value on flag
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
86
P
0.004998
AFFX-BioB-M_at
126.1
P
0.000095
AFFX-BioB-3_at
75.2
P
0.000509
AFFX-BioC-5_at
253.5
P
0.000509
AFFX-BioC-3_at
213.3
P
0.00011
AFFX-BioDn-5_at
332.4
P
0.00007
AFFX-BioDn-3_at
1574.2
P
0.000127
AFFX-CreX-5_at
2659.5
P
0.000044
AFFX-CreX-3_at
3583.5
P
0.000044
AFFX-DapX-5_at
9
A
0.185131
AFFX-DapX-M_at
9
A
0.227636
AFFX-DapX-3_at
3.3
A
0.876428
AFFX-LysX-5_at
0.7
A
0.51489
AFFX-LysX-M_at
3.1
A
0.686277
AFFX-LysX-3_at
0.8
A
0.794268
AFFX-PheX-5_at
0.9
A
0.852061
AFFX-PheX-M_at
1.8
A
0.876428
AFFX-PheX-3_at
3.3
A
0.794268
AFFX-ThrX-5_at
2
A
0.814869
AFFX-ThrX-M_at
10.2
A
0.425962
Total number of rows:
22283
Table truncated, full table size
579 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|